Works by ASTERMARK, J.

Results: 54

European principles of inhibitor management in patients with haemophilia: implications of new treatment options.

Published in:

2020

By:

Hermans, C.;
Giangrande, P. L. F.;
O'Mahony, B.;
de Kleijn, P.;
Bedford, M.;
Batorova, A.;
Blatný, J.;
Jansone, K.;
on behalf of the European Haemophilia Consortium (EHC) and the European Association for Haemophilia and Allied Disorders (EAHAD);
Astermark, J.;
Crato, M.;
d'Oiron, R.;
Dougall, A.;
Fijnvandraat, K.;
Grønhaug, S.;
Jiménez-Yuste, V.;
Jokić, M.;
Lobet, S.;
Nolan, B.;
Peyvandi, F.

Publication type:

Letter

Low recurrence rate after deep calf-vein thrombosis with 6 weeks of oral anticoagulation.

Published in:

1998

By:

Astermark;
Björgell;
Lindén;
Lethagen;
Nilsson;
Berntorp;
Astermark, Jan;
Astermark, J;
Björgell, O;
Lindén, E;
Lethagen, S;
Nilsson, P;
Berntorp, E

Publication type:

journal article

Immune tolerance induction in patients with haemophilia a and inhibitors: effectiveness and cost analysis in an European Cohort (The ITER Study).

Published in:

Haemophilia, 2016, v. 22, n. 1, p. 96, doi. 10.1111/hae.12780

By:

Rocino, A.;
Cortesi, P. A.;
Scalone, L.;
Mantovani, L. G.;
Crea, R.;
Gringeri, A.;
Altisent, C;
Astermark, J;
Diniz, MJ;
Fijnvandraat, K;
Klamroth, R;
Lambert, T;
Lavigne‐Lissalde, G;
Lopez‐Fernandez, MF;
Morfini, M

Publication type:

Article

A comparison of the treatment of patients with factor IX deficiency to that of those with factor VIII deficiency: results of an International Survey conducted as part of the International FIX Treatment Network.

Published in:

Haemophilia, 2014, v. 20, n. 5, p. e362, doi. 10.1111/hae.12487

By:

BERNTORP, E.;
SHAPIRO, A. D.;
WATERS, J.;
ASTERMARK, J.

Publication type:

Article

Managing Haemophilia for Life: 4th Haemophilia Global Summit.

Published in:

Haemophilia, 2014, v. 20, n. 5, p. 1, doi. 10.1111/hae.12468

By:

Astermark, J.;
Dolan, G.;
Hilberg, T.;
Jiménez-Yuste, V.;
Laffan, M.;
Lassila, R.;
Lobet, S.;
Martinoli, C.;
Perno, C.-F.

Publication type:

Article

A longitudinal study of family structure in Swedish persons with haemophilia.

Published in:

Haemophilia, 2014, v. 20, n. 4, p. 493, doi. 10.1111/hae.12350

By:

LÖVDAHL, S.;
HENRIKSSON, K. M.;
BAGHAEI, F.;
HOLMSTRÖM, M.;
BERNTORP, E.;
ASTERMARK, J.

Publication type:

Article

Switching clotting factor concentrates: considerations in estimating the risk of immunogenicity.

Published in:

Haemophilia, 2014, v. 20, n. 2, p. 200, doi. 10.1111/hae.12283

By:

Matino, D.;
Lillicrap, D.;
Astermark, J.;
Dolan, G.;
Kessler, C.;
Lambert, T.;
Makris, M.;
O'Donnell, J.;
Pipe, S.;
Santagostino, E.;
Saint‐Remy, J.‐M.;
Schramm, W.;
Iorio, A.

Publication type:

Article

Incidence, mortality rates and causes of deaths in haemophilia patients in Sweden.

Published in:

Haemophilia, 2013, v. 19, n. 3, p. 362, doi. 10.1111/hae.12092

By:

Lövdahl, S.;
Henriksson, K. M.;
Baghaei, F.;
Holmström, M.;
Nilsson, J.‐Å.;
Berntorp, E.;
Astermark, J.

Publication type:

Article

F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.

Published in:

Haemophilia, 2013, v. 19, n. 1, p. 113, doi. 10.1111/hae.12004

By:

Schwarz, J.;
Astermark, J.;
Menius, E. D.;
Carrington, M.;
Donfield, S. M.;
Gomperts, E. D.;
Nelson, G. W.;
Oldenburg, J.;
Pavlova, A.;
Shapiro, A. D.;
Winkler, C. A.;
Berntorp, E.

Publication type:

Article

Antibody formation and specificity in Bethesda-negative brother pairs with haemophilia A.

Published in:

Haemophilia, 2013, v. 19, n. 1, p. 106, doi. 10.1111/j.1365-2516.2012.02903.x

By:

Klintman, J.;
Hillarp, A.;
Donfield, S.;
Berntorp, E.;
Astermark, J.

Publication type:

Article

Daily dosing prophylaxis for haemophilia: a randomized crossover pilot study evaluating feasibility and efficacy.

Published in:

Haemophilia, 2012, v. 18, n. 6, p. 855, doi. 10.1111/j.1365-2516.2012.02879.x

By:

Lindvall, K.;
Astermark, J.;
Björkman, S.;
Ljung, R.;
Carlsson, K. S.;
Persson, S.;
Berntorp, E.

Publication type:

Article

Malignant disease in the haemophilic population: moving towards a management consensus?

Published in:

Haemophilia, 2012, v. 18, n. 5, p. 664, doi. 10.1111/j.1365-2516.2012.02846.x

By:

Astermark, J.;
Makris, M.;
Mauser-Bunschoten, E.;
Nemes, L.;
D'oiron, R.;
Oldenburg, J.;
Ingerslev, J.

Publication type:

Article

Prevention and prediction of inhibitor risk.

Published in:

Haemophilia, 2012, v. 18, p. 38, doi. 10.1111/j.1365-2516.2012.02827.x

By:

ASTERMARK, J.

Publication type:

Article

The international factor IX treatment network survey.

Published in:

Haemophilia, 2012, v. 18, n. 3, p. e60, doi. 10.1111/j.1365-2516.2012.02767.x

By:

BERNTORP, E.;
SHAPIRO, A. D.;
WATERS, J.;
ASTERMARK, J.

Publication type:

Article

Recommendations for assessment, monitoring and follow-up of patients with haemophilia.

Published in:

Haemophilia, 2012, v. 18, n. 3, p. 319, doi. 10.1111/j.1365-2516.2011.02671.x

By:

DE MOERLOOSE, P.;
FISCHER, K.;
LAMBERT, T.;
WINDYGA, J.;
BATOROVA, A.;
LAVIGNE-LISSALDE, G.;
ROCINO, A.;
ASTERMARK, J.;
HERMANS, C.

Publication type:

Article

Treatment of haemophilia A and B and von Willebrand's disease: summary and conclusions of a systematic review as part of a Swedish health-technology assessment.

Published in:

Haemophilia, 2012, v. 18, n. 2, p. 158, doi. 10.1111/j.1365-2516.2011.02723.x

By:

BERNTORP, E.;
ASTERMARK, J.;
BAGHAEI, F.;
BERGQVIST, D.;
HOLMSTRÖM, M.;
LJUNGBERG, B.;
NORLUND, A.;
PALMBLAD, J.;
PETRINI, P.;
STIGENDAL, L.;
SÄWE, J.

Publication type:

Article

The Arosenius Fund.

Published in:

Haemophilia, 2012, v. 18, n. 1, p. 7, doi. 10.1111/j.1365-2516.2011.02688.x

By:

ASTERMARK, J.

Publication type:

Article

Bone density and health-related quality of life in adult patients with severe haemophilia.

Published in:

Haemophilia, 2011, v. 17, n. 2, p. 304, doi. 10.1111/j.1365-2516.2010.02423.x

By:

KHAWAJI, M.;
ASTERMARK, J.;
VON MACKENSEN, S.;
ÅKESSON, K.;
BERNTORP, E.

Publication type:

Article

Clinical issues in inhibitors.

Published in:

Haemophilia, 2010, v. 16, p. 54, doi. 10.1111/j.1365-2516.2010.02294.x

By:

ASTERMARK, J.;
SANTAGOSTINO, E.;
KEITH HOOTS, W.

Publication type:

Article

Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report.

Published in:

Haemophilia, 2010, v. 16, n. 5, p. 747, doi. 10.1111/j.1365-2516.2010.02231.x

By:

ASTERMARK, J.;
ALTISENT, C.;
BATOROVA, A.;
DINIZ, M. J.;
GRINGERI, A.;
HOLME, P. A.;
KARAFOULIDOU, A.;
LOPEZ-FERNÁNDEZ, M. F.;
REIPERT, B. M.;
ROCINO, A.;
SCHIAVONI, M.;
von DEPKA, M.;
WINDYGA, J.;
FIJNVANDRAAT, K.

Publication type:

Article

Inhibitor development: patient-determined risk factors.

Published in:

2010

By:

ASTERMARK, J.

Publication type:

Report

Physical activity for prevention of osteoporosis in patients with severe haemophilia on long-term prophylaxis.

Published in:

Haemophilia, 2010, v. 16, n. 3, p. 495, doi. 10.1111/j.1365-2516.2009.02186.x

By:

KHAWAJI, M.;
ASTERMARK, J.;
ÅKESSON, K.;
BERNTORP, E.

Publication type:

Article

Thrombin generation in vitro in the presence of by-passing agents in siblings with severe haemophilia A.

Published in:

Haemophilia, 2010, v. 16, n. 1, p. e210, doi. 10.1111/j.1365-2516.2009.02132.x

By:

KLINTMAN, J.;
BERNTORP, E.;
ASTERMARK, J.

Publication type:

Article

European curriculum for thrombosis and haemostasis.

Published in:

Haemophilia, 2009, v. 15, n. 1, p. 337, doi. 10.1111/j.1365-2516.2008.01836.x

By:

ASTERMARK, J.;
NEGRIER, C.;
HERMANS, C.;
HOLME, P. A.;
KLAMROTH, R.;
KOTSI, P.;
DE MOERLOOSE, P.;
PASI, J.;
ROCINO, A.;
VON DEPKA, M.;
WINDYGA, J.;
LUDLAM, C. A.

Publication type:

Article

Thrombin generation assay: a useful routine check-up tool in the management of patients with haemophilia?

Published in:

Haemophilia, 2009, v. 15, n. 1, p. 290, doi. 10.1111/j.1365-2516.2008.01877.x

By:

SALVAGNO, G. L.;
ASTERMARK, J.;
LIPPI, G.;
EKMAN, M.;
FRANCHINI, M.;
GUIDI, G. C.;
BERNTORP, E.

Publication type:

Article

Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene.

Published in:

Haemophilia, 2009, v. 15, n. 1, p. 267, doi. 10.1111/j.1365-2516.2008.01910.x

By:

HERRMANN, F. H.;
WULFF, K.;
AUERSWALD, G.;
SCHULMAN, S.;
ASTERMARK, J.;
BATOROVA, A.;
KREUZ, W.;
POLLMANN, H.;
RUIZ-SAEZ, A.;
DE BOSCH, N.;
SALAZAR-SANCHEZ, L.

Publication type:

Article

Inhibitor Development.

Published in:

Haemophilia, 2008, v. 14, p. 36, doi. 10.1111/j.1365-2516.2008.01711.x

By:

ASTERMARK, J.;
LACROIX-DESMAZES, S.;
REDING, M. T.

Publication type:

Article

European principles of haemophilia care.

Published in:

Haemophilia, 2008, v. 14, n. 2, p. 361, doi. 10.1111/j.1365-2516.2007.01625.x

By:

Colvin, B. T.;
Astermark, J.;
Fischer, K.;
Gringeri, A.;
Lassila, R.;
Schramm, W.;
Thomas, A.;
Ingerslev, J.

Publication type:

Article

Value added: increasing the power to assess treatment outcome in joint haemorrhages.

Published in:

Haemophilia, 2008, v. 14, n. 2, p. 276, doi. 10.1111/j.1365-2516.2007.01638.x

By:

Donfield, S. M.;
Astermark, J.;
Lail, A. E.;
Gilbert, S. A.;
Berntorp, E.

Publication type:

Article

Current use of by-passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitors.

Published in:

Haemophilia, 2007, v. 13, n. 1, p. 38, doi. 10.1111/j.1365-2516.2006.01403.x

By:

ASTERMARK, J.;
ROCINO, A.;
VON DEPKA, M.;
VAN DEN BERG, H. M.;
GRINGERI, A.;
MANTOVANI, L. G.;
MORADO, M.;
GARRIDO, R. P.;
SCHIAVONI, M.;
VILLAR, A.;
WINDYGA, J.

Publication type:

Article

Impact of different inhibitor reactivities with commercial factor VIII concentrates on thrombin generation.

Published in:

Haemophilia, 2007, v. 13, n. 1, p. 51, doi. 10.1111/j.1365-2516.2006.01400.x

By:

SALVAGNO, G. L.;
ASTERMARK, J.;
EKMAN, M.;
FRANCHINI, M.;
GUIDI, G. C.;
LIPPI, G.;
POLI, G.;
BERNTORP, E.

Publication type:

Article

Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conference.

Published in:

Haemophilia, 2006, v. 12, p. 1, doi. 10.1111/j.1365-2516.2006.01359.x

By:

BERNTORP, E.;
SHAPIRO, A.;
ASTERMARK, J.;
BLANCHETTE, V. S.;
COLLINS, P. W.;
DIMICHELE, D.;
ESCURIOLA, C.;
HAY, C. R. M.;
HOOTS, W. K.;
LEISSINGER, C. A.;
NEGRIER, C.;
OLDENBURG, J.;
PEERLINCK, K.;
REDING, M. T.;
HART, C.

Publication type:

Article

Basic aspects of inhibitors to factors VIII and IX and the influence of non-genetic risk factors.

Published in:

Haemophilia, 2006, v. 12, p. 8, doi. 10.1111/j.1365-2516.2006.01360.x

By:

ASTERMARK, J.

Publication type:

Article

Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conference.

Published in:

Haemophilia, 2006, v. 12, p. 1, doi. 10.1111/j.1365-2516.2006.01359.x

By:

BERNTORP, E.;
SHAPIRO, A.;
ASTERMARK, J.;
BLANCHETTE, V. S.;
COLLINS, P. W.;
DIMICHELE, D.;
ESCURIOLA, C.;
HAY, C. R. M.;
HOOTS, W. K.;
LEISSINGER, C. A.;
NEGRIER, C.;
OLDENBURG, J.;
PEERLINCK, K.;
REDING, M. T.;
HART, C.

Publication type:

Article

Basic aspects of inhibitors to factors VIII and IX and the influence of non-genetic risk factors.

Published in:

Haemophilia, 2006, v. 12, p. 8, doi. 10.1111/j.1365-2516.2006.01360.x

By:

ASTERMARK, J.

Publication type:

Article

Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors.

Published in:

Haemophilia, 2006, v. 12, n. 4, p. 363, doi. 10.1111/j.1365-2516.2006.01296.x

By:

Astermark, J.;
Morado, M.;
Rocino, A.;
Van Den Berg, H. M.;
Von Depka, M.;
Gringeri, A.;
Mantovani, L.;
Garrido, R. P.;
Schiavoni, M.;
Villar, A.;
Windyga, J.

Publication type:

Article

Why do inhibitors develop? Principles of and factors influencing the risk for inhibitor development in haemophilia.

Published in:

Haemophilia, 2006, v. 12, p. 52, doi. 10.1111/j.1365-2516.2006.01261.x

By:

Astermark, J.

Publication type:

Article

Haemophilia Inhibitor Genetics Study – evaluation of a model for studies of complex diseases using linkage and association methods.

Published in:

Haemophilia, 2005, v. 11, n. 4, p. 427, doi. 10.1111/j.1365-2516.2005.01119.x

By:

Berntorp, E.;
Astermark, J.;
Donfield, S. M.;
Nelson, G. W.;
Oldenburg, J.;
Shapiro, A. D.;
Dimichele, D. M.;
Ewenstein, B. M.;
Gomperts, E. D.;
Winkler, C. A.

Publication type:

Article

Impact of inhibitor epitope profile on the neutralizing effect against plasma-derived and recombinant factor VIII concentrates in vitro.

Published in:

Haemophilia, 2003, v. 9, n. 5, p. 567, doi. 10.1046/j.1365-2516.2003.00802.x

By:

Astermark, J.;
Voorberg, J.;
Lenk, H.;
DiMichele, D.;
Shapiro, A.;
Tjönnfjord, G.;
Berntorp, E.

Publication type:

Article

When to start and when to stop primary prophylaxis in patients with severe haemophilia.

Published in:

Haemophilia, 2003, v. 9, p. 32, doi. 10.1046/j.1365-2516.9.s1.1.x

By:

Astermark, J.

Publication type:

Article

Consensus perspectives on prophylactic therapy for haemophilia: summary statement.

Published in:

Haemophilia, 2003, v. 9, p. 1, doi. 10.1046/j.1365-2516.9.s1.17.x

By:

Berntorp, E.;
Astermark, J.;
Björkman, S.;
Blanchette, V. S.;
Fischer, K.;
Giangrande, P. L. F.;
Gringeri, A.;
Ljung, R. C.;
Manco-Johnson, M. J.;
Morfini, M.;
Kilcoyne, R. F.;
Petrini, P.;
Rodriguez-Merchan, E. C.;
Schramm, W.;
Shapiro, A.;
M. Van Den Berg, H.;
Hart, C.

Publication type:

Article

Unresolved issues in prophylaxis.

Published in:

Haemophilia, 2002, v. 8, n. 6, p. 817, doi. 10.1046/j.1365-2516.2002.00685.x

By:

Brown, S.A.;
Aledort, L.M.;
Astermark, J.;
Berntorp, E.;
van den Berg, M.;
Blanchette, V.;
Donfield, S.;
Gringeri, A.;
Hilgartner, M.;
Kulkarni, R.;
Leissinger, C.;
Negrier, C.;
Nuss, R.;
Petterson, H.;
Petrini, P.;
Poulios, N.;
Schramm, W.

Publication type:

Article

Prophylactic treatment for severe haemophilia: comparison of an intermediate-dose to a high-dose regimen.

Published in:

Haemophilia, 2002, v. 8, n. 6, p. 753, doi. 10.1046/j.1365-2516.2002.00694.x

By:

Fischer, K.;
Astermark, J.;
Van Der Bom, J. G.;
Ljung, R.;
Berntorp, E.;
Grobbee, D. E.;
Van Den Berg, H. M.

Publication type:

Article

The Malmö International Brother Study (MIBS): further support for genetic predisposition to inhibitor development.

Published in:

Haemophilia, 2001, v. 7, n. 3, p. 267, doi. 10.1046/j.1365-2516.2001.00510.x

By:

Astermark, J.;
Berntorp, E.;
White, G. C.;
Kroner, B. L.

Publication type:

Article

The Malmö model for immune tolerance induction: impact of previous treatment on outcome.

Published in:

Haemophilia, 2000, v. 6, n. 6, p. 639, doi. 10.1046/j.1365-2516.2000.00436.x

By:

Carlborg, E.;
Astermark, J.;
Lethagen, S.;
Ljung, R.;
Berntorp, E.

Publication type:

Article

HIV-disease progression in Swedish haemophiliacs and the influence of replacement therapy.

Published in:

Haemophilia, 1997, v. 3, n. 4, p. 277, doi. 10.1046/j.1365-2516.1997.00122.x

By:

Astermark, J.;
Johnsson, H.;
Stigendal, L.;
Lethagen, S.;
Berntorp, E.

Publication type:

Article

The role of the laboratory in diagnosis and management of inhibitory antibodies in haemophilia.

Published in:

Haemophilia, 2018, v. 24, p. 9, doi. 10.1111/hae.13474

By:

Strandberg, K.;
Astermark, J.

Publication type:

Article

Surgery and survival in birth cohorts with severe haemophilia and differences in access to replacement therapy: The Malmö experience.

Published in:

Haemophilia, 2017, v. 23, n. 5, p. e403, doi. 10.1111/hae.13302

By:

Osooli, M.;
Steen Carlsson, K.;
Astermark, J.;
Berntorp, E.

Publication type:

Article

Discrepancies between the one-stage clotting assay and the chromogenic assay in haemophilia B.

Published in:

Haemophilia, 2017, v. 23, n. 4, p. 620, doi. 10.1111/hae.13219

By:

Kihlberg, K.;
Strandberg, K.;
Rosén, S.;
Ljung, R.;
Astermark, J.

Publication type:

Article

The association between health utility and joint status among people with severe haemophilia A: findings from the KAPPA register.

Published in:

Haemophilia, 2017, v. 23, p. e180, doi. 10.1111/hae.13231

By:

Osooli, M.;
Steen Carlsson, K.;
Baghaei, F.;
Holmström, M.;
Rauchensteiner, S.;
Holme, P. A.;
Hvitfeldt, L.;
Astermark, J.;
Berntorp, E.

Publication type:

Article